Inoue, Yoshitaka http://orcid.org/0000-0002-3967-7356
Okinaka, Keiji
Fuji, Shigeo
Inamoto, Yoshihiro http://orcid.org/0000-0003-4881-0427
Uchida, Naoyuki http://orcid.org/0000-0001-5952-5926
Toya, Takashi http://orcid.org/0000-0002-7436-972X
Ikegame, Kazuhiro http://orcid.org/0000-0002-5421-7470
Eto, Tetsuya
Ozawa, Yukiyasu
Iwato, Koji
Kanda, Yoshinobu http://orcid.org/0000-0002-4866-9307
Atsuta, Yoshiko http://orcid.org/0000-0003-4404-2870
Ogata, Masao http://orcid.org/0000-0002-4896-5878
Fukuda, Takahiro
,
Funding for this research was provided by:
The National Cancer Center Research and Development Fund
Article History
Received: 10 June 2020
Revised: 11 March 2021
Accepted: 29 March 2021
First Online: 19 April 2021
Compliance with ethical standards
:
: YA reports Honoraria (e.g., lecture fees) from Chugai Pharmaceutical Co. Ltd, Kyowa Kirin Co., Ltd, Bristol-Myers Squibb Co., Ltd, Yakult Honsha Co., Ltd., Janssen Pharmaceutical K.K., and Otsuka Pharmaceutical Co., Ltd, outside the submitted work. The other authors declare no competing interests associated with this paper.